Gemcitabine and vascular toxicity.
A
A
Muñoz
J M
JM
Mañé
I
I
Rubio
R
R
Fernández
N
N
Fuente
R
R
Barceló
G
G
López Vivanco
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D003841:Deoxycytidine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006504:Hepatic Veno-Occlusive Disease / Q000139:chemically induced*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome; D014657:Vasculitis / Q000139:chemically induced*; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine